Poster SessionsP1.01-016 Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2017 Published by Elsevier Inc.